A double-blind randomised placebo controlled study to evaluate the effects of different doses of testosterone from a Testosterone Metered-Dose Transdermal Spray (MDTS) on sexual function in premenopausal women with low libido

Phase 2

Completed

• Conditions: ow libido in post menopausal women suffering from low serum testosterone; Low libido in post menopausal women suffering from low serum testosterone; Reproductive Health and Childbirth - Menstruation and menopause

• Registration Number: ACTRN12605000481673
• Lead Sponsor: FemPharm Pty Ltd and/or Acrux DDS Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

Postmenopausal women suffering from low libido with low serum testosterone who are otherwise healthy.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of satisfactory sexual events compared to placebo after 16 weeks[After 16 weeks]

Secondary Outcome Measures

Name	Time	Method
Frequency of satisfactory and total sexual events at other timepoints throughout the study.[]